![Stacy Coen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacy Coen
Directeur/Membre du Conseil chez
FIBROBIOLOGICS, INC.
Fortune : 435 $ au 31/05/2026
Profil
Stacy A. Coen is currently Independent Director at FibroBiologics, Inc. since 2021.
Currently Chief Business Officer & Senior Vice President at ImmunoGen, Inc. since 2020.
Currently a Member of the Massachusetts Biotechnology Council.
Currently a Trustee of Huntington's Disease Society of America.
Currently a Member of the Alliance for Regenerative Medicine.
Former Vice President at Genzyme Corp.
Former Vice President-Business Development at Editas Medicine, Inc. Completed undergraduate studies at the University of Massachusetts.
Earned an MBA from the University of Virginia Darden School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,01 % | 24/04/2026 | 375 ( 0,01 % ) | 435 $ | 31/05/2026 |
Postes actifs de Stacy Coen
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 03/06/2020 |
| FIBROBIOLOGICS, INC. | Directeur/Membre du Conseil | 01/07/2021 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Corporate Officer/Principal | - |
Huntington's Disease Society of America | Directeur/Membre du Conseil | - |
Anciens postes connus de Stacy Coen
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | - |
Formation de Stacy Coen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Huntington's Disease Society of America | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
